Sirolimus Eluting Coronary Stent System
- UID
- IMP/MD/2023/001207_dd9e936185c45bb38483da5470752fd4_fab568c1a32f8e18f6b3fb9908a4c296
- Device class
- Class D
- Brand name
- Ultimaster Nagomi
- License holder
- M/s. Terumo India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Ultimaster Nagomi Sirolimus eluting coronary stent system is a sterile, single use implantable drug (Ultimaster Nagomi) eluting stent mounted on a semi-compliant balloon delivery catheter, intended to improve myocardial blood flow in patients with stenotic or occlusive lesions in coronary arteries.
Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/001207_dd9e936185c45bb38483da5470752fd4_fab568c1a32f8e18f6b3fb9908a4c296. This device is marketed under the brand name Ultimaster Nagomi. The license holder is M/s. Terumo India Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.